ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.

about

ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.

Item

http://www.wikidata.org/entity/Q55013294

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

ICG fluorescence imaging as a ...... fter neoadjuvant chemotherapy.

@en

ICG fluorescence imaging as a ...... fter neoadjuvant chemotherapy.

@nl

type

Item

label

ICG fluorescence imaging as a ...... fter neoadjuvant chemotherapy.

@en

ICG fluorescence imaging as a ...... fter neoadjuvant chemotherapy.

@nl

prefLabel

ICG fluorescence imaging as a ...... fter neoadjuvant chemotherapy.

@en

ICG fluorescence imaging as a ...... fter neoadjuvant chemotherapy.

@nl

P1476

ICG fluorescence imaging as a ...... after neoadjuvant chemotherapy

@en

P2093

Danielle Noterman

http://www.w3.org/2001/XMLSchema#string

Denis Larsimont

http://www.w3.org/2001/XMLSchema#string

Filip De Neubourg

http://www.w3.org/2001/XMLSchema#string

Gabriel Liberale

http://www.w3.org/2001/XMLSchema#string

Isabelle Veys

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Nogaret

http://www.w3.org/2001/XMLSchema#string

Michel Moreau

http://www.w3.org/2001/XMLSchema#string

Pierre Bourgeois

http://www.w3.org/2001/XMLSchema#string

Romain Barbieux

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review.

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

Application of intraoperative indocyanine green angiography for CNS tumors: results on the first 100 cases.

Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement

Intraoperative indocyanine green fluorescence guidance for excision of nonpalpable breast cancer.

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

P304

e0197857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0197857

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

F C Pop

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29799849

http://www.w3.org/2001/XMLSchema#string

P932

5969773

http://www.w3.org/2001/XMLSchema#string